Sees 2H and FY24 positive adjusted free cash flow to exceed 50% of adjusted EBITDA, including full year interest expense of $160M-$165M and CapEx of ~$170M, excluding reagent rentals.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: